Please assess the completion status of the following clinical trial:

Trial Title: The Role of Trans-spinal Direct Current Stimulation (tsDCS) in Treating Patients With Hand Spasticity After Stroke

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE1/PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. First single focal unilateral hemisphere lesion with diagnosis verified by brain imaging (MRI or CT scans) that occurred at least 6 months prior~2. Cognitive function sufficient to understand the experiments and follow instructions~3. A Modified Ashworth Scale score between 1-3 points for wrist flexor and extensor muscles~4. A minimum of 15 degrees wrist passive range of motion (ROM) for wrist flexion and extension from wrist neutral position~Exclusion Criteria:~1. Focal brainstem or thalamic infarcts~2. Prior surgical treatments for spasticity of the upper limb~3. Ongoing use of central nervous system (CNS)-active medications~4. Ongoing use of psychoactive medications, such as stimulants, antidepressants, and anti-psychotic medications~5. Botox or phenol alcohol treatment within 12 weeks of enrollment~6. Pregnancy in women, as determined by self-report~7. History of spinal cord injury or weakness~8. Chronic pain~9. Peripheral neuropathy including insulin dependent diabetes as determined by case history~10. Presence of additional potential tsDCS risk factors:~    * Damaged skin at the site of stimulation (i.e., skin with ingrown hairs, acne, razor nicks, wounds that have not healed recent scar tissue, broken skin, etc.)~   * Presence of an electrically, magnetically or mechanically activated implant (including cardiac pacemaker), an intracerebral vascular clip, or any other electrically sensitive support system~   * Highly conductive metal in any part of the body, including metal injury to the eye (jewelry must be removed during stimulation)~   * Past history of seizures or unexplained spells of loss of consciousness during the previous 36 months

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Sham Doublestim (Type: PLACEBO_COMPARATOR): Participants first received 5 daily, consecutive 20 min sessions of sham Doublestim (trans-spinal direct current stimulation + peripheral direct current stimulation). After a washout period of 1 week, they then received 5 daily, consecutive 20 min sessions of anodal Doublestim (trans-spinal direct current stimulation + peripheral direct current stimulation). For all participants, the sham condition preceded the anodal Doublestim condition.
- Anodal Doublestim (Type: ACTIVE_COMPARATOR): Participants first received 5 daily, consecutive 20 min sessions of sham Doublestim (trans-spinal direct current stimulation + peripheral direct current stimulation). After a washout period of 1 week, they then received 5 daily, consecutive 20 min sessions of anodal Doublestim (trans-spinal direct current stimulation + peripheral direct current stimulation). For all participants, the sham condition preceded the anodal Doublestim condition.

Based on this trial design, predict the completion outcome and termination type (if applicable).